Compare PRCT & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRCT | OCSL |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2021 | 2007 |
| Metric | PRCT | OCSL |
|---|---|---|
| Price | $19.83 | $11.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 6 |
| Target Price | ★ $22.25 | $12.50 |
| AVG Volume (30 Days) | ★ 1.2M | 449.7K |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 11.02% |
| EPS Growth | ★ 1.71 | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $308,054,000.00 | N/A |
| Revenue This Year | $28.32 | N/A |
| Revenue Next Year | $20.48 | N/A |
| P/E Ratio | ★ N/A | $56.33 |
| Revenue Growth | ★ 37.22 | N/A |
| 52 Week Low | $16.67 | $10.63 |
| 52 Week High | $38.11 | $14.31 |
| Indicator | PRCT | OCSL |
|---|---|---|
| Relative Strength Index (RSI) | 56.43 | 39.14 |
| Support Level | $17.00 | $11.28 |
| Resistance Level | $19.87 | $12.35 |
| Average True Range (ATR) | 0.99 | 0.26 |
| MACD | 0.23 | -0.01 |
| Stochastic Oscillator | 93.25 | 27.78 |
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.